Capecitabine
Treatment Xeloda 
At what stage is this treatment used?
 
  • Adjuvant treatment of stage III (Dukes C) colon cancer. 
  • Treatment of advanced or metastatic bowel cancer alone or in combination. 
 
Is this drug available via the Pharmaceutical Benefits Scheme (PBS) as a subsidised treatment? 

  • Capecitabine is PBS-subsidised as a treatment option for advanced or metastatic colorectal cancer.  
  • Capecitabine is PBS-subsidised as a treatment option for adjuvant treatment of stage III (Dukes C) colon cancer, following complete resection of the primary tumour.
  • Capecitabine is not PBS-subsidised for the treatment of patients with Stage II (Dukes B) colon cancer.
  • Capecitabine is not PBS-subsidised for the adjuvant treatment of patients with rectal cancer.
  • Capecitabine in combination with oxaliplatin (XELOX) is listed as a PBS-subsidised treatment option for the adjuvant treatment of stage III (Dukes C) colon cancer, which allows Xeloda to be reimbursed as both monotherapy and as part of the XELOX combination.

Download the Consumer Medicine Information (CMI) for Xeloda.
 
 
 
Bowel Cancer Australia Helpline
Bowel Cancer Australia Bowel Cancer App